Q4 2019 |
24 |
$118M |
+$2.28M |
-$303M |
-$300M |
TDG, MA, V, TPL, PYPL
|
13F-HR |
2/14/2020, 05:09 PM |
Q3 2019 |
31 |
$387M |
+$37.6M |
-$50.5M |
-$13M |
TDG, V, MA, ADSK, TPL
|
13F-HR |
11/14/2019, 06:05 AM |
Q2 2019 |
27 |
$407M |
+$30.5M |
-$26M |
+$4.52M |
TDG, V, MA, TPL, AMZN
|
13F-HR |
8/14/2019, 10:00 AM |
Q1 2019 |
28 |
$380M |
+$28.1M |
-$78.9M |
-$50.8M |
TDG, V, MA, PANW, MTN
|
13F-HR |
5/15/2019, 08:00 AM |
Q4 2018 |
31 |
$359M |
+$71.4M |
-$67.6M |
+$3.79M |
V, TDG, GDDY, HBAN, MA
|
13F-HR |
2/14/2019, 01:06 PM |
Q3 2018 |
30 |
$420M |
+$27.4M |
-$65.3M |
-$37.9M |
V, AMZN, MA, TDG, HBAN
|
13F-HR |
11/14/2018, 06:30 AM |
Q2 2018 |
30 |
$419M |
+$53.1M |
-$120M |
-$67.4M |
V, HBAN, AMZN, MTN, MA
|
13F-HR |
8/14/2018, 06:42 AM |
Q1 2018 |
30 |
$456M |
+$45.8M |
-$89.7M |
-$43.9M |
UNVR, ADSK, V, NOW, HBAN
|
13F-HR |
5/15/2018, 06:06 AM |
Q4 2017 |
29 |
$474M |
+$33.2M |
-$102M |
-$68.6M |
NOW, UNVR, V, AMZN, ADSK
|
13F-HR |
2/14/2018, 03:45 PM |
Q3 2017 |
28 |
$505M |
+$57.3M |
-$106M |
-$48.8M |
UNVR, V, TEAM, EXPE, NOW
|
13F-HR |
11/14/2017, 01:41 PM |
Q2 2017 |
27 |
$526M |
+$51M |
-$94.3M |
-$43.3M |
EXPE, FLT, AMZN, SYF, V
|
13F-HR |
8/14/2017, 11:26 AM |
Q1 2017 |
25 |
$537M |
+$82.3M |
-$245M |
-$162M |
SBAC, CHTR, LBTYK, SYF, AMZN
|
13F-HR |
5/15/2017, 10:33 AM |
Q4 2016 |
25 |
$648M |
+$69.6M |
-$192M |
-$123M |
AFSI, CHTR, SBAC, LBTYK, AMZN
|
13F-HR |
2/14/2017, 04:06 PM |
Q3 2016 |
29 |
$790M |
+$66.2M |
-$191M |
-$125M |
AFSI, CHTR, SBAC, EXPE, LBTYK
|
13F-HR |
11/14/2016, 06:42 AM |
Q2 2016 |
27 |
$865M |
+$95M |
-$148M |
-$52.9M |
AFSI, EXPE, CHTR, SBAC, LBTYK
|
13F-HR |
8/15/2016, 03:40 PM |
Q1 2016 |
26 |
$909M |
+$73.5M |
-$85.1M |
-$11.6M |
CHTR, SBAC, AFSI, EXPE, LBTYK
|
13F-HR |
5/16/2016, 03:23 PM |
Q4 2015 |
28 |
$960M |
+$84.6M |
-$135M |
-$50.8M |
CHTR, SBAC, EXPE, AFSI, LBTYK
|
13F-HR |
2/16/2016, 09:10 AM |
Q3 2015 |
29 |
$958M |
+$130M |
-$95.3M |
+$34.4M |
CHTR, LBTYK, PCLN, QRTEA, V
|
13F-HR |
11/13/2015, 10:57 AM |
Q2 2015 |
26 |
$985M |
+$108M |
-$76.9M |
+$30.8M |
CHTR, LBTYK, QRTEA, AFSI, GILD
|
13F-HR |
8/14/2015, 07:47 AM |
Q1 2015 |
24 |
$924M |
+$117M |
-$178M |
-$61M |
LBTYK, CHTR, AFSI, GILD, QRTEA
|
13F-HR |
5/15/2015, 06:04 AM |
Q4 2014 |
24 |
$991M |
+$110M |
-$243M |
-$133M |
AFSI, LBTYK, CHTR, GILD, CRI
|
13F-HR |
2/17/2015, 04:24 PM |
Q3 2014 |
27 |
$1.09B |
+$149M |
-$189M |
-$40.3M |
AFSI, SBAC, CHTR, ASPS, AAMC
|
13F-HR |
11/14/2014, 06:11 AM |
Q2 2014 |
26 |
$1.19B |
+$158M |
-$113M |
+$44.8M |
OCN, ASPS, CHTR, AFSI, SBAC
|
13F-HR |
8/14/2014, 10:19 AM |
Q1 2014 |
28 |
$1.16B |
+$343M |
-$217M |
+$126M |
OCN, ASPS, CHTR, CCI, AAMC
|
13F-HR |
5/15/2014, 06:24 AM |
Q4 2013 |
27 |
$1.1B |
$0 |
$0 |
|
OCN, SBAC, AAMC, ASPS, CHTR
|
13F-HR |
2/14/2014, 06:17 AM |